EditCo Bio launched an automated CRISPR platform designed to handle scale work by building and validating cell models across genes, cell backgrounds, and experimental conditions.
Public source
Publisher name
Public post
AI can quickly identify potential targets, gene relationships, biomarkers, and mechanisms. But a prediction is only the starting point. Researchers still need to test th…
Company
EditCo Bio
Edit with Precision, Accelerate with Confidence
- Industry
- Biotechnology Research
- Location
- Redwood City, US
- Company size
- 51–200 employees
About EditCo Bio
We provide high-quality engineered cell models built for precision and reproducibility. Our genome engineering offerings include CRISPR knockouts (KO), knock-ins (KI), and endogenous protein tagging, along with CRISPR Reagents including Gene knock out kits, CRISPR libraries, and nucleases and controls. Extended QC (NGS, WGS, karyotyping, functional validation) ensures accurate edits and reliable, publication-ready results.
See moreLatest activity
Latest activity from EditCo Bio
5 signals
Research & Knowledge
EditCo Bio published new work in Nature Methods combining single-cell perturbation screens with transfer learning to reconstruct signaling histories.
Products & Services
EditCo Bio offers Arrayed Screening Libraries as part of a limited-time offer.
Research & Knowledge
EditCo Bio highlights that a team at the Broad Institute of MIT and Harvard published a new method to track gene activity in living cells over time using engineered cells that release RNA into the surrounding medium.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Synthego
Synthego launched the Synthego New Lab Startup Program to provide exclusive molecular biology reagents and CRISPR products for startups opening new labs.
Products & Services
Prolific Machines
Prolific Machines launched its optogenetic CLD platform using light to enable precise, dynamic, and tunable control of gene expression, significantly boosting titers while providing control over critical quality attributes.
Products & Services
Integrated DNA Technologies
Integrated DNA Technologies developed UNCOVERseq™ to provide a more sensitive, reproducible, and standardized approach to off-target nomination for CRISPR-based therapies.
Products & Services
pixlbio
pixlbio offers pixCRISPR, a gene-editing and differentiation service for disease models including LDLR, SERPINA1, ATP7B, OTC, ASS1, ABCB11, PAH, and custom targets.
Products & Services
4basebio